Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Treatment crawled date : 2021 - 11 - 02 save search
Lilly to Supply 614,000 Additional Doses of AbCellera-Discovered Bamlanivimab Together with Etesevimab to the U.S. Government for the Treatment or Post-Exposure Prevention of COVID-19
Published: 2021-11-02 (Crawled : 23:00) - biospace.com/
ABCL | $3.88 -0.77% -0.77% 980K
|
|
| O: -0.41%
H: 5.54%
C: 4.54%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.55%
H: 0.0%
C: 0.0%
covid treatment
uniQure Announces Latest Positive Recommendation from Data Safety Monitoring Board in Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
Published: 2021-11-02 (Crawled : 17:00) - biospace.com/
QURE | $4.68 -0.64% -0.64% 550K
|
Health Technology
|
| O: -0.63%
H: 9.62%
C: 8.29%
huntington disease treatment test positive trial huntington’s disease
TCT 2021: Philips announces new innovations and clinical data supporting the treatment of patients with cardiovascular disease
Published: 2021-11-02 (Crawled : 15:00) - globenewswire.com
PHG | $19.98 0.0% 540K
|
Health Technology
|
| O: 0.44%
H: 0.25%
C: -0.42%
disease treatment cardiovascular cardio
Lilly to supply 614,000 additional doses of bamlanivimab and etesevimab to the U.S. Government for the treatment or post-exposure prevention of COVID-19
Published: 2021-11-02 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.26%
H: 2.0%
C: 1.15%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.55%
H: 0.0%
C: 0.0%
covid treatment
Landos Biopharma Announces FDA Clearance of its IND for LABP-104 for the Treatment of Rheumatoid Arthritis
Published: 2021-11-02 (Crawled : 13:00) - biospace.com/
LABP | $21.74 -0.05% -0.05% 15K
|
|
| O: 3.63%
H: 0.49%
C: -2.52%
fda clearance treatment fda biopharma rheumatoid arthritis clearance
Diabetes Associated Ophthalmic Treatment Market Size $44.7 Billion By 2028: Grand View Research, Inc.
Published: 2021-11-02 (Crawled : 10:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 2.06%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.3%
H: 0.15%
C: -0.4%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.26%
H: 2.0%
C: 1.15%
diabetes treatment research
Mental Health Treatments for Older Adults
Published: 2021-11-02 (Crawled : 08:00) - brainsway.com
BWAY | $4.835 0.94% 0.93% 41K
|
Health Technology
|
| O: 0.12%
H: 0.67%
C: 0.67%
treatment health order
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.